The biomarkers market research reports analyze the global biomarkers industry. These research reports review and e...
The biomarkers market research reports analyze the global biomarkers industry. These research reports review and evaluate the worldwide market for biomarkers. Biomarkers play a vital role in diagnosis and drug discovery. They are biochemical features of cells that, either directly or indirectly, provide information about the presence of a disease and its increase (or decrease) and effects of a drug on the disease. Though still in infancy, biomarkers have been immensely used in the discovery and development of targeted cancer therapies and related diagnostics. These research reports cover the markets for biomarkers applications, technologies, products and services. The biomarkers applications cover markets such as personalized medicine and the diagnosis and treatment markets for various disease conditions such as cardiovascular diseases, cancer, neurological disorders and autoimmune diseases. The applications also includes the drug discovery market, which in turn covers submarkets such as ADME-TOX profiling, drug targets and process quality assurance in drug development.
These market research reports also give an analysis of the biomarkers discovery technologies including Genomics, Bioinformatics, Molecular Imaging, Proteomics and others. These reports classify the biomarkers technologies segment into the pre-genomic and post-genomic technology markets. The previous includes technologies such as immunodiagnostics, enzyme and metabolite assays and molecular diagnostics; while the latter includes technologies such as metabolites, transcriptomics and imaging biomarkers. The biomarkers services segment is bifurcated into the markets for pre and post clinical services such as sample preparation, mRNA analysis and miRNA analysis, antibody development, assay development and production and validation and reporting.
These market research reports provide the most accurate study of the market for biomarkers available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the biomarkers arena. These market research reports are designed in such a manner that you will find their briefing on the emerging market for biomarkers essential. These market research reports provide detailed information on how this promising application for biomarkers is already shaping the market, producing millions in revenue which is expected to multiply in the coming years. Further these research reports discuss the major products currently marketed in each disease category as well as the important issues and trends that serious entrants into this market must take notice of.
These biomarkers research reports analyze and forecast the revenues for all of these markets; and also provide comprehensive data on the factors affecting market growth, such as regulatory issues on genomics, proteomics and molecular diagnostics in various geographies. Biomarkers markets are estimated according to share of markets for various technologies and applications like proteomics, metabolomics, molecular diagnostics, drug discovery, clinical trials and bioinformatics. These research reports further split the market values according to therapeutic applications and major geographical areas. These reports provide rich statistical analysis of the global and the regional markets including the United States, Europe, Asia-Pacific and Rest of World. Unfulfilled needs in biomarkers are identified as well as the drivers for biomarkers markets are highlighted. These reports also discuss the challenges that the biomarker industry is facing and also help in devising strategies for the development of the biomarkers market.
These research reports provide in-depth profiles of the key companies in this market which include Biophysical Corp., Charles River Laboratories Inc., Cyclacel Pharmaceuticals Inc., DeCODE Genetics, Diologic Corp., Health Discovery Corp., Illumina Inc., Imgenex Corp., Insilicos LLC, Metabolon Inc., Millennium Pharmaceuticals Inc., Peakadilly, PPD Inc., Proteome Sciences plc, Rules-Based Medicine Inc., Targeted Molecular Diagnostics LLC, amongst others.